|
1
|
Grisariu S, Avni B, Batchelor TT, van den
Bent MJ, Bokstein F, Schiff D, Kuittinen O, Chamberlain MC, Roth P,
Nemets A, et al: Neurolymphomatosis: An international primary CNS
lymphoma collaborative group report. Blood. 115:5005–5011. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Khong P, Pitham T and Owler B: Isolated
neurolymphomatosis of the cauda equina and filum terminale: Case
report. Spine (Phila Pa 1976). 33:E807–E811. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Baehring JM, Damek D, Martin EC, Betensky
RA and Hochberg FH: Neurolymphomatosis. Neuro Oncol. 5:104–115.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lagarde S, Tabouret E, Matta M, Franques
J, Attarian S, Pouget J, De Paula Maues A, Figarella-Branger D,
Dory-Lautrec P, Chinot O and Barrié M: Primary neurolymphomatosis
diagnosis and treatment: A retrospective study. J Neurol Sci.
342:178–181. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Deckert M, Paulus W, Kluin PM and Ferry
JA: Diffuse large B-cell lymphoma of the CNSLouis DN, Ohgaki H,
Wiestler OD and Cavenee WK: WHO Classification of Tumours of the
Central Nervous System. WHO/IARC Classification of Tumours,
Revised. 4th edition. 1. IAR Press; Lyon: pp. 272–275. 2016
|
|
6
|
Mauney M and Sciotto CG: Primary malignant
lymphoma of the cauda equina. Am J Surg Pathol. 7:185–190. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Toner GC, Holmes R, Sinclair RA, Tang SK
and Schwarz MA: Central nervous system lymphoma: Primary lumbar
nerve root infiltration. Acta Haematol. 81:44–47. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Klein P, Zientek G, VandenBerg SR and
Lothman E: Primary CNS lymphoma: Lymphomatous meningitis presenting
as a cauda equina lesion in an AIDS patient. Can J Neurol Sci.
17:329–331. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Knopp EA, Chynn KY and Hughes J: Primary
lymphoma of the cauda equina: Myelographic, CT myelographic, and MR
appearance. AJNR Am J Neuroradiol. 15:1187–1189. 1994.PubMed/NCBI
|
|
10
|
Ooi GC, Peh WC and Fung CF: Case report:
Magnetic resonance imaging of primary lymphoma of the cauda equina.
Br J Radiol. 69:1057–1060. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Giobbia M, Carniato A, Scotton PG, Vaglia
A and Marchiori GC: Primary EBV-associated cauda equina lymphoma. J
Neurol. 246:739–740. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zagami AS and Granot R: Non-Hodgkin's
lymphoma involving the cauda equina and ocular cranial nerves: Case
reports and literature review. J Clin Neurosci. 10:696–699. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kumar N and Dyck PJ: Hypertrophy of the
nerve roots of the cauda equina as a paraneoplastic manifestation
of lymphoma. Arch Neurol. 62:1776–1777. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tajima Y, Sudo K and Matumoto A: Malignant
lymphoma originating in the cauda equina mimicking the inflammatory
polyradiculoneuropathy. Intern Med. 46:1029–1032. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Morita M, Osawa M, Naruse H and Nakamura
H: Primary NK/T-cell lymphoma of the cauda equina: A case report
and literature review. Spine (Phila Pa 1976). 34:E882–E885. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Beitzke M, Enzinger C, Beitzke D,
Neureiter D, Ladurner G and Fazekas F: Primary leptomeningeal
lymphoma of the cauda equina: A rare cause of radiculopathy. J
Neurol. 257:1734–1737. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Teo MK, Mathieson C, Carruthers R, Stewart
W and Alakandy L: Cauda equina lymphoma-a rare presentation of
primary central nervous system lymphoma: Case report and literature
review. Br J Neurosurg. 26:868–871. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cugati G, Singh M, Symss NP, Pande A,
Vasudevan MC and Ramamurthi R: Primary spinal intradural
extramedullary lymphoma causing cauda equina syndrome. J
Craniovertebr Junction Spine. 3:58–61. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Iwasaki M, Hida K, Yano S, Aoyama T,
Kaneko S and Iwasaki Y: Primary cauda equina lymphoma treated with
high-dose methotrexate. Neurol Med Chir (Tokyo). 52:679–683. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nishida H, Hori M and Obara K: Primary
B-cell lymphoma of the cauda equina, successfully treated with
high-dose methotrexate plus high-dose cytarabine: A case report
with MRI findings. Neurol Sci. 33:403–407. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nakashima H, Imagama S, Ito Z, Ando K,
Kobayashi K, Ukai J, Muramoto A, Shinjyo R, Matsumoto T, Yamauchi
I, et al: Primary cauda equina lymphoma: Case report and literature
review. Nagoya J Med Sci. 76:349–354. 2014.PubMed/NCBI
|
|
22
|
Broen M, Draak T, Riedl RG and Weber WE:
Diffuse large B-cell lymphoma of the cauda equina. BMJ Case Rep.
2014:pii: bcr2014205950. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shin HK, Oh SK, Woo CG, Huh JR, Suh CW and
Jeon SR: Cauda equina lymphoma mimicking non-neoplastic
hypertrophic neuropathy of the cauda equina: A case report. Br J
Neurosurg. 30:678–680. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Belcastro V, Bellcocchi S, Patriarca C,
Gini G, Piola M, Barca S and Arnaboldi M: Cauda equina syndrome due
to large B-cell lymphoma: A case report. Neurol Sci. 37:825–827.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang G, Liu Y and He F: Primary lymphoma
involving cranial nerves and cauda equina detected by (18)F-FDG
PET/CT and MRI. Nuklearmedizin. 55:N46–N48. 2016.PubMed/NCBI
|
|
26
|
Hochberg FH and Miller DC: Primary central
nervous system lymphoma. J Neurosurg. 68:835–853. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Goto N, Tsurumi H, Goto H, Shimomura YI,
Kasahara S, Hara T, Yasuda I, Shimizu M, Murakami N, Yoshikawa T,
et al: Serum soluble interleukin-2 receptor (sIL-2R) level is
associated with the outcome of patients with diffuse large B cell
lymphoma treated with R-CHOP regimens. Ann Hematol. 91:705–714.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kitai R, Sasaki H, Matsuda K, Tsunetoshi
K, Yamauchi T, Neishi H, Matsumura K, Tsunoda A, Takeuchi H, Sato K
and Kikuta K: Measurement and cellular sources of the soluble
interleukin-2 receptor in primary central nervous system lymphoma.
Brain Tumor Pathol. 30:34–39. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Boukhris S, Magy L, Kabore R, Mabrouk T,
Li Y, Sindou P, Tabaraud F and Vallat JM: Atypical
electrophysiologic findings in chronic inflammatory demyelinating
polyneuropathy (CIDP)-diagnosis confirmed by nerve biopsy.
Neurophysiol Clin. 34:71–79. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Miyazaki Y, Nawa Y, Miyagawa M, Kohashi S,
Nakase K, Yasukawa M and Hara M: Maximum standard uptake value of
18F-fluorodeoxyglucose positron emission tomography is a prognostic
factor for progression-free survival of newly diagnosed patients
with diffuse large B cell lymphoma. Ann Hematol. 92:239–244. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hong CM, Lee SW, Lee HJ, Song BI, Kim HW,
Kang S, Jeong SY, Ahn BC, Lee J and Chae YS: Neurolymphomatosis on
F-18 FDG PET/CT and MRI findings: A case report. Nucl Med Mol
Imaging. 45:76–78. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Grommes C and DeAngelis LM: Primary CNS
lymphoma. J Clin Oncol. 35:2410–2418. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ferreri AJ, Reni M, Foppoli M, Martelli M,
Pangalis GA, Frezzato M, Cabras MG, Fabbri A, Corazzelli G,
Ilariucci F, et al: High-dose cytarabine plus high-dose
methotrexate versus high-dose methotrexate alone in patients with
primary CNS lymphoma: A randomised phase 2 trial. Lancet.
374:1512–1520. 2009. View Article : Google Scholar : PubMed/NCBI
|
